Testing effectiveness (Phase 2)Study completedNCT01397305
What this trial is testing
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Who this might be right for
Rectal Cancer
Isofol Medical AB 24